Acute Myelocytic Leukemia

Search Trials
Economic Analysis of Blood Product Transfusions According to the Treatment of Acute Myeloid Leukaemia in the Elderly
Status:
Completed
Last Changed:
Jul 27, 2016
First Changed:
Jul 27, 2016
Disease(s):
Acute Myeloid Leukemia
Intervention(s):
Transfusion
Accelerated Dose Schedule of Cytarabine Consolidation Therapy for Patients With Acute Myeloid Leukemia (AML) in Complete Remission
Status:
Not yet recruiting
Last Changed:
Jun 4, 2021
First Changed:
Jun 4, 2021
Disease(s):
Acute Myeloid Leukemia
Intervention(s):
CytarabineCytarabine
Study to Assess Dasatinib in Patients With Core Binding Factors Acute Myelogenous Leukemia
Status:
Completed
Last Changed:
Apr 14, 2014
First Changed:
Apr 14, 2014
Disease(s):
Acute Myelogenous Leukemia
Intervention(s):
dasatinib
A Phase Ib, Open-label, Multi-center Dose-finding Study of Oral Panobinostat (LBH589) in Combination With Ara-C and Mitoxantrone as Salvage Therapy for Refractory or Relapsed Acute Myeloid Leukemia
Status:
Completed
Last Changed:
Dec 19, 2020
First Changed:
Jan 25, 2010
Disease(s):
Acute Myeloid Leukemia
Intervention(s):
panobinostat/LBH589B
Phase I/II Trial of S65487 Plus Azacitidine in Acute Myeloid Leukemia
Status:
Recruiting
Last Changed:
Apr 6, 2022
First Changed:
Feb 5, 2021
Disease(s):
Acute Myeloid Leukemia
Intervention(s):
S65487 and azacitidine

Connect. Empower. Inspire.